Literature DB >> 12111476

Hippocampal neurons in schizophrenia.

S Heckers1, C Konradi.   

Abstract

The hippocampus is crucial for normal brain function, especially for the encoding and retrieval of multimodal sensory information. Neuropsychiatric disorders such as temporal lobe epilepsy, amnesia, and the dementias are associated with structural and functional abnormalities of specific hippocampal neurons. More recently we have also found evidence for a role of the hippocampus in the pathophysiology of schizophrenia. The most consistent finding is a subtle, yet significant volume difference in schizophrenia. Here we review the cellular and molecular basis of smaller hippocampal volume in schizophrenia. In contrast to neurodegenerative disorders, total hippocampal cell number is not markedly decreased in schizophrenia. However, the intriguing finding of a selective loss of hippocampal interneurons deserves further study. Two neurotransmitter receptors, the GABAA and AMPA/kainate glutamate receptors, appear to be abnormal, whereas changes of the NMDA glutamate receptor are less robust. The expression of several genes, including those related to the GABAergic system, neurodevelopment, and synaptic function, is decreased in schizophrenia. Taken together, recent studies of hippocampal cell number, protein expression, and gene regulation point towards an abnormality of hippocampal architecture in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111476      PMCID: PMC4205576          DOI: 10.1007/s007020200073

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  70 in total

Review 1.  Glutamate receptors in the mammalian central nervous system.

Authors:  S Ozawa; H Kamiya; K Tsuzuki
Journal:  Prog Neurobiol       Date:  1998-04       Impact factor: 11.685

2.  Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia.

Authors:  R H Porter; S L Eastwood; P J Harrison
Journal:  Brain Res       Date:  1997-03-21       Impact factor: 3.252

3.  GABAergic neuronal subtypes in the human frontal cortex--development and deficits in schizophrenia.

Authors:  G P Reynolds; C L Beasley
Journal:  J Chem Neuroanat       Date:  2001-07       Impact factor: 3.052

4.  Thalamic and amygdala-hippocampal volume reductions in first-degree relatives of patients with schizophrenia: an MRI-based morphometric analysis.

Authors:  L J Seidman; S V Faraone; J M Goldstein; J M Goodman; W S Kremen; R Toomey; J Tourville; D Kennedy; N Makris; V S Caviness; M T Tsuang
Journal:  Biol Psychiatry       Date:  1999-10-01       Impact factor: 13.382

5.  Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain.

Authors:  S L Eastwood; P W Burnet; P J Harrison
Journal:  Synapse       Date:  2000-06-01       Impact factor: 2.562

6.  Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia.

Authors:  G P Reynolds; C Czudek; H B Andrews
Journal:  Biol Psychiatry       Date:  1990-05-01       Impact factor: 13.382

7.  Magnetic resonance imaging of brain in people at high risk of developing schizophrenia.

Authors:  S M Lawrie; H Whalley; J N Kestelman; S S Abukmeil; M Byrne; A Hodges; J E Rimmington; J J Best; D G Owens; E C Johnstone
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

8.  Topographically specific hippocampal projections target functionally distinct prefrontal areas in the rhesus monkey.

Authors:  H Barbas; G J Blatt
Journal:  Hippocampus       Date:  1995       Impact factor: 3.899

9.  Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem.

Authors:  R Kerwin; S Patel; B Meldrum
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

10.  Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain.

Authors:  M S Todtenkopf; F M Benes
Journal:  Synapse       Date:  1998-08       Impact factor: 2.562

View more
  72 in total

Review 1.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

Review 2.  Developmental pathology, dopamine, stress and schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Int J Dev Neurosci       Date:  2010-08-19       Impact factor: 2.457

3.  Cognitive disorganization in hippocampus: a physiological model of the disorganization in psychosis.

Authors:  Andrey V Olypher; Daniel Klement; André A Fenton
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

4.  Twenty-first century brain banking. Processing brains for research: the Columbia University methods.

Authors:  Jean Paul G Vonsattel; Maria Pilar Del Amaya; Christian E Keller
Journal:  Acta Neuropathol       Date:  2007-11-06       Impact factor: 17.088

5.  Hippocampal Network Modularity Is Associated With Relational Memory Dysfunction in Schizophrenia.

Authors:  Suzanne N Avery; Baxter P Rogers; Stephan Heckers
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-02-22

6.  Investigating the neuroimmunogenic architecture of schizophrenia.

Authors:  R Birnbaum; A E Jaffe; Q Chen; J H Shin; J E Kleinman; T M Hyde; D R Weinberger
Journal:  Mol Psychiatry       Date:  2017-05-09       Impact factor: 15.992

Review 7.  Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

8.  Extinction memory is impaired in schizophrenia.

Authors:  Daphne J Holt; Kelimer Lebron-Milad; Mohammed R Milad; Scott L Rauch; Roger K Pitman; Scott P Orr; Brittany S Cassidy; Jared P Walsh; Donald C Goff
Journal:  Biol Psychiatry       Date:  2008-11-04       Impact factor: 13.382

9.  Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study.

Authors:  Gregor Habl; Mathias Zink; Georg Petroianu; Manfred Bauer; Thomas Schneider-Axmann; Martina von Wilmsdorff; Peter Falkai; Fritz A Henn; Andrea Schmitt
Journal:  J Neural Transm (Vienna)       Date:  2009-10-13       Impact factor: 3.575

10.  A Cognitive Neuroscience View of Schizophrenic Symptoms: Abnormal Activation of a System for Social Perception and Communication.

Authors:  Cynthia G Wible; Alexander P Preus; Ryuichiro Hashimoto
Journal:  Brain Imaging Behav       Date:  2009-03-01       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.